🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

🧪

Trial Match

Clinical trials test new treatments — sometimes the newest options available for a disease. Find trials that are recruiting now, near you. Open one to see its eligibility rules as simple questions to go through with your doctor.

Know your stage or your test results (such as EGFR, HER2 or BRCA)? Match trials to your own profile - nothing you type is saved.

🎯 Match trials to me

4 recruiting trials

for Zhejiang University

The Impact of Fexofenadine Hydrochloride on the Prognosis of Patients Post-Acute Myocardial Infarction NCT07381803Phase 31 site📍 Hangzhou Second Affiliated Hospital, Zhejiang University, School of … · Tests: Fexofenadine 60 Mg Oral Tablet, Placebo Valvular Heart Disease Registry Study in Second Affiliated Hospital of ZheJiang University NCT03011697n/a1 site📍 Hangzhou Second Affiliated Hospital, Zhejiang University, School of … Diagnosis and Treatment of Foreign Bodies Outside Pharynx and Esophagus Lumen NCT04917367n/a1 site📍 Hangzhou Second Affiliated Hospital, Zhejiang University, School of … · Tests: exploratory surgery A Retrospective Study on the Relationship Between Donor Leukocyte Telomere Length and Prognosis of Acute Leukemia Patients Treated With Allogeneic Hematopoietic Stem Cell Transplantation NCT06076226n/a1 site📍 Hangzhou Zhejiang University · Tests: No intervention, observation study
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy